Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department

被引:12
作者
Kauppila, Mirjam [1 ,2 ]
Backman, Janne T. [1 ,2 ,3 ]
Niemi, Mikko [1 ,2 ,3 ]
Lapatto-Reiniluoto, Outi [1 ,2 ]
机构
[1] Univ Helsinki, Dept Clin Pharmacol, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Individualized Drug Therapy Res Program, Fac Med, Helsinki, Finland
关键词
Adverse drug reaction; Antithrombotics; Cytostatics; Preventability; Pharmacogenetics; IMPLEMENTATION CONSORTIUM GUIDELINES; CPIC GUIDELINES; EVENTS; ADMISSIONS; GENOTYPE; VISITS; FREQUENCY; AGREEMENT; SEVERITY; THERAPY;
D O I
10.1007/s00228-020-03043-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose To investigate the characteristics of ADRs in patients admitting at the emergency room of a tertiary hospital. Methods We collected the patient records of 1600 emergency room visits of a university hospital in 2018. The patient files were studied retrospectively and all possible ADRs were identified and registered. Patient characteristics, drugs associated with ADRs, causality, severity, preventability, and the role of pharmacogenetics were assessed. Results There were 125 cases with ADRs, resulting in a 7.8% overall incidence among emergency visits. The incidence was greatest in visits among elderly patients, reaching 14% (men) to 19% (women) in the 80-89 years age group. The most common causative drugs were warfarin, acetylsalicylic acid (ASA), apixaban, and docetaxel, and the most common ADRs were bleedings and neutropenia and/or severe infections. Only two of the cases might have been prevented by pharmacogenetic testing, as advised in Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines. Conclusion The same ATC classes, antithrombotics and cytostatics, were involved in ADRs causing university clinic hospitalizations as those identified previously in drug-related hospital fatalities. It seems difficult to prevent these events totally, as the treatments are vitally important and their risk-benefit-relationships have been considered thoroughly, and as pharmacogenetic testing could have been useful in only few cases.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 48 条
[1]   Medications Related Emergency Admissions: Causes and Recommendations [J].
Aldardeer, Namareq ;
Benslimane, Nabila ;
Khalifa, Mohamed .
INFORMATICS EMPOWERS HEALTHCARE TRANSFORMATION, 2017, 238 :169-172
[2]   A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting [J].
Alhawassi, Tariq M. ;
Krass, Ines ;
Bajorek, Beata V. ;
Pont, Lisa G. .
CLINICAL INTERVENTIONS IN AGING, 2014, 9 :2079-2086
[3]   Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil [J].
Alves de Araujo Lobo, Marcia Germana ;
Botelho Pinheiro, Sandra Maria ;
Diaz Castro, Jose Gerley ;
Momente, Valeria Gomes ;
Pranchevicius, Maria-Cristina S. .
BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14
[4]   Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update [J].
Amstutz, Ursula ;
Henricks, Linda M. ;
Offer, Steven M. ;
Barbarino, Julia ;
Schellens, Jan H. M. ;
Swen, Jesse J. ;
Klein, Teri E. ;
McLeod, Howard L. ;
Caudle, Kelly E. ;
Diasio, Robert B. ;
Schwab, Matthias .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) :210-216
[5]   Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital [J].
Aspinall, MB ;
Whittle, J ;
Aspinall, SL ;
Maher, RL ;
Good, CB .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (09) :841-845
[6]   A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions [J].
Belhekar, Mahesh N. ;
Taur, Santosh R. ;
Munshi, Renuka P. .
INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (01) :117-120
[7]   Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing [J].
Birdwell, K. A. ;
Decker, B. ;
Barbarino, J. M. ;
Peterson, J. F. ;
Stein, C. M. ;
Sadee, W. ;
Wang, D. ;
Vinks, A. A. ;
He, Y. ;
Swen, J. J. ;
Leeder, J. S. ;
van Schaik, R. H. N. ;
Thummel, K. E. ;
Klein, T. E. ;
Caudle, K. E. ;
MacPhee, I. A. M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (01) :19-24
[8]   Regional surveillance of emergency-department visits for outpatient adverse drug events [J].
Capuano, A. ;
Irpino, A. ;
Gallo, M. ;
Ferrante, L. ;
Illiano, M. L. ;
Rinaldi, B. ;
Filippelli, A. ;
Rossi, F. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (07) :721-728
[9]   Detection of patients presenting with adverse drug events in the emergency department [J].
Chen, Y. -C. ;
Fan, J. -S. ;
Hsu, T. -F. ;
Chen, M. -H. ;
Huang, H. -H. ;
Cheng, K. -W. ;
Yen, D. H. -T. ;
Huang, M. -S. ;
Lee, C. -H. ;
Chen, L. -K. ;
Yang, C. -C. .
INTERNAL MEDICINE JOURNAL, 2012, 42 (06) :651-657
[10]   Comparing Characteristics of Adverse Drug Events Between Older and Younger Adults Presenting to a Taiwan Emergency Department [J].
Chen, Yen-Chia ;
Huang, Hsien-Hao ;
Fan, Ju-Sing ;
Chen, Min-Hui ;
Hsu, Teh-Fu ;
Yen, David Hung-Tsang ;
Huang, Mu-Shung ;
Wang, Chien-Ying ;
Huang, Chun-I ;
Lee, Chen-Hsen .
MEDICINE, 2015, 94 (07) :e547